154 related articles for article (PubMed ID: 34779773)
1. Remifentanil-Induced Symmetric Drug-Related Intertriginous and Flexural Exanthema: A Diagnostic Challenge in an Intensive Care Patient.
Martins JF; Alen Coutinho I; Castro M; Carvalho J; Faria C; Sousa E; Martins P
J Investig Allergol Clin Immunol; 2022 Oct; 32(5):399-401. PubMed ID: 34779773
[No Abstract] [Full Text] [Related]
2. Everolimus-induced Symmetrical Drug-related Intertriginous and Flexural Exanthema.
Kim EY; Awh KC; Larocca CA
Acta Derm Venereol; 2023 Dec; 103():adv12197. PubMed ID: 38112207
[No Abstract] [Full Text] [Related]
3. A case of symmetrical drug-related intertriginous and flexural exanthema-like eruption associated with Pfizer COVID-19 vaccination.
Manaa A; Ziv M; Krausz J; Dodiuk-Gad RP
Dermatol Ther; 2022 Jul; 35(7):e15546. PubMed ID: 35485220
[No Abstract] [Full Text] [Related]
4. Symmetrical drug related intertriginous and flexural exanthema (SDRIFE) induced by fluconazole: An uncommon side effect of a commonly used drug.
Kumar S; Bhale G; Brar BK
Dermatol Ther; 2019 Nov; 32(6):e13130. PubMed ID: 31659833
[No Abstract] [Full Text] [Related]
5. A systematic approach to systemic contact dermatitis and symmetric drug-related intertriginous and flexural exanthema (SDRIFE): a closer look at these conditions and an approach to intertriginous eruptions.
Winnicki M; Shear NH
Am J Clin Dermatol; 2011 Jun; 12(3):171-80. PubMed ID: 21469762
[TBL] [Abstract][Full Text] [Related]
6. Remdesivir-induced symmetrical drug-related intertriginous and flexural exanthema (SDRIFE)? A case report with review of the literature.
Heck J; Stichtenoth DO; Mettin R; Jöckel J; Bickel C; Krichevsky B
Eur J Clin Pharmacol; 2021 Jan; 77(1):141-144. PubMed ID: 32761371
[No Abstract] [Full Text] [Related]
7. A rare case of symmetrical drug-related intertriginous and flexural exanthema due to pantoprazole.
Kothari R; Pal R; Bhatnagar A; Kishore K; Patil C
Int J Dermatol; 2022 Sep; 61(9):e330-e331. PubMed ID: 35235207
[No Abstract] [Full Text] [Related]
8. Symmetrical Drug-Related Intertriginous and Flexural Exanthema (SDRIFE) Caused by Etoricoxib.
Caralli ME; Seoane Rodríguez M; Rojas Pérez-Ezquerra P; Pelta Fernández R; De Barrio Fernández M
J Investig Allergol Clin Immunol; 2016; 26(2):128-9. PubMed ID: 27164635
[No Abstract] [Full Text] [Related]
9. A case of fixed drug eruption induced by doxycycline, mimicking a symmetrical drug-related intertriginous and flexural exanthema (SDRIFE).
Favrelière S; Hosteing S; Jazeron JF; Allouchery M; Lafay-Chebassier C; Perault-Pochat MC
Therapie; 2020; 75(5):511-513. PubMed ID: 31761151
[No Abstract] [Full Text] [Related]
10. Symmetrical drug-related intertriginous and flexural exanthema-like rash related to severe acute respiratory syndrome coronavirus 2 infection.
Escolà H; March-Rodriguez A; Pujol RM
Indian J Dermatol Venereol Leprol; 2023; 89(1):119-121. PubMed ID: 36331827
[No Abstract] [Full Text] [Related]
11. Lenalidomide-induced symmetrical drug-related intertriginous and flexural exanthema.
Patel RT; Quan EY; Eikenberg JD; Grider DJ; Phillips MA
Dermatol Online J; 2023 Aug; 29(4):. PubMed ID: 37921816
[TBL] [Abstract][Full Text] [Related]
12. Docetaxel-induced symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) confirmed by skin testing.
Hampel A; Kinaciyan T
Contact Dermatitis; 2024 May; 90(5):525-527. PubMed ID: 38263696
[No Abstract] [Full Text] [Related]
13. Reply to "A case of symmetrical drug-related intertriginous and flexural exanthema-like eruption associated with Pfizer COVID-19 vaccination" by Manaa et al.
Camela E; Scalvenzi M; Megna M; Potestio L; Guerrasio G; Fornaro L; Fabbrocini G; Costa C
Dermatol Ther; 2022 Dec; 35(12):e15881. PubMed ID: 36181410
[No Abstract] [Full Text] [Related]
14. Symmetrical drug-related intertriginous and flexural exanthema-like eruption: An addition to the spectrum of coronavirus disease 2019-related cutaneous findings.
Çakıcı ÖA; Güder S; Salman A; Ergun T
Indian J Dermatol Venereol Leprol; 2022; 88(6):814-816. PubMed ID: 36332096
[No Abstract] [Full Text] [Related]
15. Levofloxacin-induced symmetric drug-related intertriginous and flexural exanthema.
Tsai YW; Chung WH; Wang CW; Cheng CY
Contact Dermatitis; 2022 Jan; 86(1):64-66. PubMed ID: 34553784
[No Abstract] [Full Text] [Related]
16. Symmetrical drug-related intertriginous and flexural exanthema (baboon syndrome) with fever induced by oral cloxacillin: does fever confound the diagnosis?
Chong WS; Lim HL
J Dermatol; 2010 Sep; 37(9):830-2. PubMed ID: 20883371
[No Abstract] [Full Text] [Related]
17. Symmetrical drug-related intertriginous and flexural exanthema caused by valacyclovir.
Daito J; Hanada K; Katoh N; Katoh S; Sakamoto K; Asai J; Takenaka H; Kishimoto S
Dermatology; 2009; 218(1):60-2. PubMed ID: 18974630
[TBL] [Abstract][Full Text] [Related]
18. First Case of Symmetric Drug-Related Intertriginous and Flexural Exanthema Induced by Meropenem.
Blanco Garcia-Granero D; Barranco R; García-Moguel I; Velasco V; Diéguez Pastor MC
J Investig Allergol Clin Immunol; 2021 Dec; 31(6):516-517. PubMed ID: 33661103
[No Abstract] [Full Text] [Related]
19. Symmetric Drug-Related Intertriginous and Flexural Exanthema.
Mansilla Polo M; Martín-Torregrosa D
N Engl J Med; 2024 Feb; 390(7):e17. PubMed ID: 38354144
[No Abstract] [Full Text] [Related]
20. Symmetric drug-related intertriginous and flexural exanthema-like eruption related to coronavirus disease 2019 vaccine.
Hong JK; Shin SH; Yoo KH; Li K; Seo SJ
Contact Dermatitis; 2022 Jul; 87(1):91-93. PubMed ID: 35243643
[No Abstract] [Full Text] [Related]
[Next] [New Search]
